Roger Halualani has over 30 years of experience with pharmaceutical and biotechnology products and has worked in multiple facets of the industry including research, manufacturing, product development, marketing and sales, business development, and strategic planning. In addition, Roger has exceptional knowledge of the international markets, especially the U.S., Europe, and Japan. His therapeutic areas of expertise include oncology, rheumatology, dermatology, infectious disease, and cardiology, to name a few. His areas of business expertise include epidemiology, forecasting, strategic planning, market research, corporate partnering, pricing and reimbursement, and new product development. Roger is one of the founders of of Epiphany Partners Inc., an epidemiology data analytics company, and Halualani & Associates, a DEI consulting firm to the non-profit and education fields.